Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
April 06, 2021 at 05:50 am
Share
Teyi Pharmaceutical Group Co.,Ltd announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 63,269.52 compared to CNY 92,112.23 a year ago. Operating income was CNY 5,822.15 compared to CNY 19,757.62 a year ago. Net income was CNY 4,381.65 compared to CNY 17,171.04 a year ago. Basic earnings per share from continuing operations was CNY 0.22 compared to CNY 0.85 a year ago.
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
TEYI PHARMACEUTICAL GROUP CO.,LTD 
